Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Kocsis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|August 24, 2018
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated DiseasesJózsef Dobó, Andrea Kocsis, Péter Gál
Immunobiology|June 5, 2007
Serine proteases of the classical and lectin pathways: similarities and differencesPéter Gál, László Barna, Andrea Kocsis, et al.
Frontiers in Immunology|July 25, 2022
Proprotein Convertases and the Complement SystemJózsef Dobó, Andrea Kocsis, Ráhel Dani, et al.
The Journal of Biological Chemistry|April 7, 2019
Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitorsDávid Szakács, Andrea Kocsis, Róbert Szász, et al.
International Journal of Molecular Sciences|February 10, 2024
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) SystemsJózsef Dobó, Andrea Kocsis, Bence Farkas, et al.
The Biochemical Journal|December 18, 2025
Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanismsBarbara Végh, Andrea Kocsis, József Dobó, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2012
Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2Dávid Héja, Andrea Kocsis, József Dobó, et al.
International Journal of Molecular Sciences|July 13, 2024
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin PathwayAndrea Kocsis, Dalma Bartus, Edit Hirsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activationAndrea Kocsis, Katalin A Kékesi, Róbert Szász, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2018
Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway ActivationKatalin Paréj, Andrea Kocsis, Csenge Enyingi, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|August 24, 2018
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated DiseasesJózsef Dobó, Andrea Kocsis, Péter Gál
Immunobiology|June 5, 2007
Serine proteases of the classical and lectin pathways: similarities and differencesPéter Gál, László Barna, Andrea Kocsis, et al.
Frontiers in Immunology|July 25, 2022
Proprotein Convertases and the Complement SystemJózsef Dobó, Andrea Kocsis, Ráhel Dani, et al.
The Journal of Biological Chemistry|April 7, 2019
Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitorsDávid Szakács, Andrea Kocsis, Róbert Szász, et al.
International Journal of Molecular Sciences|February 10, 2024
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) SystemsJózsef Dobó, Andrea Kocsis, Bence Farkas, et al.
The Biochemical Journal|December 18, 2025
Efficient production of fully active, SARS-CoV-2-priming, wildtype TMPRSS2 ectodomain via co-expression of HAI-2 allows for both auto- and cross-activation mechanismsBarbara Végh, Andrea Kocsis, József Dobó, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2012
Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2Dávid Héja, Andrea Kocsis, József Dobó, et al.
International Journal of Molecular Sciences|July 13, 2024
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin PathwayAndrea Kocsis, Dalma Bartus, Edit Hirsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activationAndrea Kocsis, Katalin A Kékesi, Róbert Szász, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2018
Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway ActivationKatalin Paréj, Andrea Kocsis, Csenge Enyingi, et al.
Pageof 2